Physician profile
Eugene Gu
NPI 1659753176
$399.47
in general payments reported to CMS, 2019-2025
11 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $53.96 · 2024: $29.75 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $67.67 | 2025 | |
| Novo Nordisk INC | $52.00 | 2025 | Ozempic |
| Janssen Pharmaceuticals, INC | $50.07 | 2024-2025 | Spravato |
| Madrigal Pharmaceuticals | $35.11 | 2025 | Rezdiffra |
| Exact Sciences Corporation | $35.00 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $30.00 | 2025 | Jardiance |
| Abbvie INC. | $29.63 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.57 | 2022 | |
| Merck Sharp & Dohme LLC | $25.81 | 2025 | M-M-R II, Gardasil 9, Capvaxive |
| Bayer Healthcare Pharmaceuticals INC. | $25.39 | 2022 | |
| Xeris Pharmaceuticals, INC. | $20.22 | 2025 | Recorlev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Gu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.